Specialist Trainee Clinical Fellowship in Product Development Oncology​/Haematology; PDOH

Position: Specialist Trainee Clinical Fellowship in Product Development Oncology/Haematology (PDOH)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections,  where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come.

Join Roche, where every voice matters.### ### The Position### Job Purpose The Roche Clinical Fellowship is aimed at current specialist trainees (StR/SpR).Established in 2013, the program was designed to diversify and broaden clinical training through exposure to clinical research methodology from the pharmaceutical medicine perspective. The fellowship will be 1 year in duration, primarily based at Roche Products Ltd in Welwyn Garden City, UK.

The position is within the Clinical Development Group, which is responsible for the strategy, design and execution of late phase clinical trials in oncology, haemato-oncology and non-malignant haematology disease areas. Depending on your specialist area of training,  the fellowship can be tailored to these interests. There will be the opportunity for direct interaction across Roche/Genentech. There may be opportunities to  attend scientific conferences, depending on the project and programme.

Your supervisor will be an experienced member of the Clinical Development Group working in Welwyn.  In addition, you will be assigned a mentor who is a UK accredited Physician. In order to take up the post, you will be expected to have an Out Of Program (OOP) absence approved by your Training Programme Director/Deanery.
* Oncology/Haematology (PDOH), which incorporates the following areas of specialty:  + Oncology  + Haemato-oncology (lymphoid and myeloid)  + Non-malignant haematology (haemophilia and allied bleeding disorders, gene therapy, thrombosis)### The Opportunity As a Fellow in the Global Clinical Development Group you may:
* Be involved in the design, execution, data review, analysis and interpretation of data from clinical studies for molecules in development as well as marketed compounds.
* Interact with globally recognised academic experts and clinical investigators
* Participate in key clinical strategy, implementation and molecule management meetings in order to gain a deeper understanding of the complexities and challenges of  the development of medicines
* Provide clinical expertise in the disease area for cross functional pharmaceutical development teams
* Contribute to the generation of abstracts and oral presentations for key external conferences and other specialty meetings as well as publication opportunities.
* Be involved in discussions and initiatives around Personalised Health Care (PHC) and patient selection for different therapeutic interventions
* Collaborations between pharmaceutical companies, the health service and academia are key to improving patient outcomes and care
* Understanding drug development, regulation and the reimbursement process is critical for physicians wishing to influence the delivery of healthcare
* Our fellowships offer a unique insight training for those wishing to participate or conduct clinical trials in their future careers
* Scope for research opportunities using large impactful datasets and the chance to work with academic experts### Who You Are
* An ST3+ trainee looking to diversify their training. While some previous clinical research experience is preferred, it is not essential.
* A trainee interested in further understanding and influencing the development and approval of medicines for patients within the specific disease area.

Note:

this is not intended to be a basic science fellowship leading to a post graduate degree, although the clinical research could supplement or inform existing basic research if appropriate.### Application Process
* Phase I: CV & Cover Letter screen,Please ensure you include a CV and cover letter with your initial application (DO NOT USE QUICK APPLY OPTION) any application without a cover letter is automatically declined.
As part of your cover letter, Roche is keen to understand your motivation in applying for this position.  You should, therefore, provide responses to the following questions:

Your cover letter should not exceed one page.
* Phase II:
Video Interview - details will be shared with shortlisted candidates.

Purpose:

In both stages, our focus is to understand
* why* you are applying for this role and
* what* you will bring to ensure team and personal success. We look forward to learning more about you and your motivation to join our team.
* Phase III:
Assessment Centre - details will be shared with shortlisted candidates.

Disclosure note:
For 2026-27 the Roche Oncology/Haematology Clinical Development Group will appoint one Specialist Trainee Clinical Fellow. Fellowship start date ~ September/October 2026.
** Final date to receive applications:
** 30th January 2026  ### Who we areA…